CD79A and breast cancer: We also evaluated the effects of CD79A+CD24-PANCK+-BCSCs subpopulation and CD8+FOXP3+ T cells on breast cancer patients survive status, finding that both CD79A+CD24-PANCK+-BCSCs cells-High and CD8+FOXP3+ cells-High (within 50 μm to CD79A+CD24-PANCK+-BCSCs subpopulation) had poorer survival probability (Fig. 9e, f), further indicating that these two groups of cells contribute to poor prognosis may due to the tumor immunosuppressive microenvironment they shaped.